
Imbrium Therapeutics
Biotechnology, 201 Tresser BLVD, Stamford, Connecticut, 06901, United States, 11-50 Employees
Phone Number: +12*********
Who is IMBRIUM THERAPEUTICS
Imbrium is a clinical-stage biopharmaceutical company dedicated to advancing medical science through the development of important new pharmacologic and biologic therapeutics. We are pursu...
Read More

-
Headquarters: 201 Tresser BLVD, Stamford, Connecticut, 06901, United States
-
Date Founded: 2018
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 7311
Does something look wrong? Fix it. | View contact records from IMBRIUM THERAPEUTICS
Imbrium Therapeutics Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Imbrium Therapeutics
Answer: Imbrium Therapeutics's headquarters are located at 201 Tresser BLVD, Stamford, Connecticut, 06901, United States
Answer: Imbrium Therapeutics's phone number is +12*********
Answer: Imbrium Therapeutics's official website is https://imbriumthera.com
Answer: Imbrium Therapeutics's revenue is $1 Million to $5 Million
Answer: Imbrium Therapeutics's SIC: 7311
Answer: Imbrium Therapeutics has 11-50 employees
Answer: Imbrium Therapeutics is in Biotechnology
Answer: Imbrium Therapeutics contact info: Phone number: +12********* Website: https://imbriumthera.com
Answer: Imbrium is a clinical-stage biopharmaceutical company dedicated to advancing medical science through the development of important new pharmacologic and biologic therapeutics. We are pursuing oncology chemotherapeutics, treatments for disorders of the central nervous system, and non-opioid approaches to the management of pain. As an operating subsidiary of Purdue Pharma L.P., Imbrium strives to develop and bring to market new medicines that serve the unmet needs of patients, physicians and health systems worldwide. We have built a robust and diversified pipeline of investigational drug candidates, and we actively collaborate with industry and academic partners to identify and advance future impactful medicines. LinkedIn posts may include discussion of investigational products that have not been approved by FDA, and for which safety or effectiveness have not been established. There is no guarantee they will successfully complete development or gain FDA approval.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface

Sign in to CIENCE GO Data to uncover contact details
Free credits every month